Name | Title | Contact Details |
---|---|---|
Ed Gudaitis |
President and Chief Executive Officer | Profile |
Pathalys Pharma, Inc. is a private, late-stage clinical biopharmaceutical company committed to the development of multiple advanced therapeutics that address unmet needs in the management of end stage kidney disease (ESKD). Pathalys` initial asset is upacicalcet, a novel calcimimetic with the potential to improve the treatment of SHPT in hemodialysis patients. Beyond upacicalcet, Pathalys continues to identify other high priority needs and potential solutions for patients with ESKD. Pathalys is headquartered in Research Triangle Park, North Carolina.
Cytovia is dedicated to the development of transformational cancer immunotherapies, addressing several of the most challenging unmet medical needs including the prevention of cancer relapse and metastasis. Cytovia focuses on Natural Killer (NK) cell biology and applies precision medicine tools to develop the right therapy for the right patient at the right stage of the disease. Cytovia has secured access to multiple advanced technologies, including allogeneic cell therapy, multispecific antibodies, and cytokines. Cytovia establishes development partnerships to accelerate time-to-market and commercialization alliances in order to optimize rapid adoption of its novel immunotherapies.
GENACTICS is a Fort Washington, PA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Advanced Urology provides cutting-edge Vasectomy, Circumcision, InterStim, Urolift, Cytoscopy, TURP, Vasectomy Reversal & IPP. Contact us today for an initial consult.
BioVest International is a Tampa, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.